Sign in
Taking people in United StatesEarly phase 1

Imaging Mitochondrial Complex-I in Cocaine Use Disorder: a [F-18]BCPP-EF PET Study

Key facts

Who runs it
Rajesh Narendran
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Recruiting
Phase
Early phase 1
People taking part
40 people, planned
Started
4 Sept 2026
Expected to end
31 Dec 2029
Type of study
Interventional
Treatments tested
  • [F-18]BCPP-EF
Record updated
14 September 2026

Who can take part

Age
18 years to 45 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 14 criteriaShow less

Other criteria

  • Cocaine use disorders (CUD)
  • Males or females between 18 and 45 years old
  • fulfill DSM-5 criteria for moderate or severe (4+ criteria) cocaine use disorder
  • No lifetime DSM-5 schizophrenia, schizoaffective disorder, bipolar disorder, and developmental disorders
  • No comorbid DSM-5 major depressive or severe anxiety disorders (including cocaine-induced mood and anxiety disorders) in the past 12 months
  • No comorbid DSM-5 alcohol, opioids, sedative-hypnotics, hallucinogens, and inhalant use disorders in the past 12 months. Subjects with a moderate to severe DSM-5 cannabis use disorder will also be excluded
  • Not currently on psychotropic or medical medications that can influence binding to MC-I (e.g., metformin) or CGM (e.g., insulin, GLP-1 agonists), or increase the risks associated with an arterial line (e.g., warfarin, clopidogrel, aspirin, naproxen, ibuprofen, etc.)
  • No comorbid medical disorders that can influence the PET outcome measures (for example, MC-I binding is altered in Parkinson' disease, mild or major neurocognitive disorders, mitochondrial disorders, immune disorders; and CGM is altered in diabetes, severe hyperlipidemia, hypertension, obesity), or are a contraindication for blood sampling (anemia), or placement of an arterial line (history of deep vein thrombosis, pulmonary embolism, thrombocytopenia or thrombocytosis)
  • Not currently pregnant or breast-feeding
  • Not currently employed as radiation worker; or has not participated in a radiation-related research protocol within the previous year such that the total cumulative annual radiation dose (i.e., from participation in previous radioactive drug studies and this study) would exceed the radiation dose limits specified in the FDA regulations (i.e., 21 CFR 361.1) that govern the research use of radiotracers
  • No medical or psychiatric contraindications to undergo an MRI scan (such as ferromagnetic tattoos/piercings, implants, medical equipment, history of gunshot, and claustrophobia); Healthy controls (HC)
  • Males or females between 18 and 45 years old
  • No DSM-5 psychiatric or substance use disorder other than tobacco use disorder
  • 6 to 10 above

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

Where in United States

  • University of PittsburghPittsburgh, United StatesContact: Rajesh NarendranTaking people

About the trial

What the trial wants to find out

Studies proposed in this application will image mitochondrial Complex-I in cocaine use disorder (CUD) and matched healthy controls

The group in the trial

  • PETTreatment being tested

    \[F-18\]BCPP-EF

    Treatment: [F-18]BCPP-EF

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Imaging Brain Energy Use in Cocaine Use Disorder: a [F-18]BCPP-EF PET Study
Criteria questions
Built from NCT07773649, who can take part
Record updated
14 September 2026